Basic Information
| LncRNA/CircRNA Name | n377806 |
| Synonyms | NA |
| Region | NA |
| Ensemble | NA |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | nasopharyngeal cancer |
| ICD-0-3 | C11 |
| Methods | RNA-seq, qPCR etc. |
| Sample | cell lines (CNE-2,5-8F and 6-10B) |
| Expression Pattern | down-regulated |
| Function Description | Compared with the deep sequencing prediction findings, qRT-PCR verified that the same significant differential expression trends were presented in 7 of 8 lncRNAs, which included all the known lncRNAs (n375709, n377806, n369241 and n335785) and 3 novel lncRNAs (Unigene6646, Unigene6644 and Unigene1654). |
| Pubmed ID | 27498905 |
| Year | 2016 |
| Title | Next generation deep sequencing identified a novel lncRNA n375709 associated with paclitaxel resistance in nasopharyngeal carcinoma. |
External Links
| Links for n377806 | GenBank HGNC NONCODE |
| Links for nasopharyngeal cancer | OMIM COSMIC |